References
- El-Sayed YY. Obstetric and gynecologic care of women with epilepsy. Epilepsia. 1998;39(8):S17–S2.
- Morrell MJ. Reproductive and metabolic disorders in women with epilepsy. Epilepsia. 2003;44(4):11–20.
- Harden CL, Pennell PB, Koppel BS, et al. Management issues for women with epilepsy – focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breast-feeding: report of the quality standards subcommittee and therapeutics and technology assessment subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. 2009;50:1247–1255.
- Reddy DS. The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy. Epilepsy Res. 2009;85:1–30.
- Reddy DS. Neurosteroids and their role in sex-specific epilepsies. Neurobiol Dis. 2014a;2:198–209.
- Reddy DS. Catamenial epilepsy: discovery of an extrasynaptic molecular mechanism for targeted therapy. Front Cell Neurosci. 2016;10(101):1–12.
- Rogawski MA, Löscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci. 2004;5:553–564.
- French JA, Pedly TA. Initial management of epilepsy. N Engl J Med. 2008;359:166–176.
- Reddy DS. Clinical pharmacology of current antiepileptic drugs. Int J Pharm Sci Nanotech. 2014b;7(1):2305–2319.
- Hatcher RA, Nelson A. Combined hormonal contraceptive methods. In: Hatcher RA, Ed. Contraceptive technology. 18th ed. NY, USA: Ardent Media; 2004. p. 391–460.
- Crawford P. Best practice guidelines for the management of women with epilepsy. Epilepsia. 2005;46(9):117–124.
- Sabers A, Öhman I, Christensen J, et al. Oral contraceptives reduce lamotrigine plasma levels. Neurol. 2003;61:570–571.
- Herzog AG, Blum AS, Farina EL, et al. Valproate and lamotrigine level variation with menstrual cycle phase and oral contraceptive use. Neurol. 2009;72:911–914.
- Wegner I, Wilhelm AJ, Lambrechts DA, et al. Effect of oral contraceptives on lamotrigine levels depends on comedication. Acta Neurol Scand. 2014;129(6):393–398.
- Zaccara G, Perucca E. Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs. Epileptic Disord. 2014;16(4):409–432.
- Stockis A, Watanabe S, Fauchoux N. Interaction between brivaracetam (100mg/day) and a combination oral contraceptive: a randomized, double-blind, placebo-controlled study. Epilepsia. 2014;55(3):e27-31.
- Crawford P, Chadwick D, Cleland P. The lack of effect of sodium valproate on the pharmacokinetics of oral contraceptive steroids. Contraception. 1986;33:23–29.
- Harden CL, Leppik I. Optimizing therapy of seizures in women who use oral contraceptives. Neurol. 2006;67(4):S56–S58.
- Reddy DS. Clinical pharmacokinetic interactions between antiepileptic drugs and hormonal contraceptives. Expert Rev Clin Pharmacol. 2010;3(2):183–192.
- Crawford P, Chadwick DJ, Martin C. The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids. Br J Clin Pharmacol. 1990;30:892–896.
- Scharfman HE, MacLusky NJ. The influence of gonadal hormones on neuronal excitability, seizures and epilepsy in the female. Epilepsia. 2006;47:1423–1440.
- Vessey M, Painter R, Yeates D. Oral contraception and epilepsy. Contraception. 2002;66:77–79.
- Herzog AG. Differential impact of antiepileptic drugs on the effects of contraceptive methods on seizures: interim findings of the epilepsy birth control registry. Seizure. 2015;28:71–75.
- Herzog AG, Mandle HB, Cahill KE, et al. Contraceptive practices of women with epilepsy: findings of the epilepsy birth control registry. Epilepsia. 2016a;57:630–637.
- Herzog AG, Mandle HB, Cahill KE, et al. Differential impact of contraceptive methods on seizures varies by antiepileptic drug category: findings of the epilepsy birth control registry. Epilepsy Behav. 2016b;60:112–117.
- Zoler ML. Hormonal contraceptives may increase epileptic seizures. Neurol Rev. 2016 Jan;30–33.
- Reddy DS. Role of hormones and neurosteroids in epileptogenesis. Front Cell Neurosci. 2013;31(115):1–13.
- Bäckström T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol Scand. 1976;54:321–347.
- Jacono JJ, Robinson J. The effects of estrogen, progesterone, and ionized calcium on seizures during the menstrual cycle in epileptic women. Epilepsia. 1987;28:571–577.
- Logothetis J, Harner R, Morrel F. The role of estrogens in catamenial exacerbation of epilepsy. Neurol. 1959;9:352–360.
- Sibai BM, Odlind V, Meador ML, et al. A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (ortho evra/evra). Fertil Steril. 2002;77(2.2):S19–26.
- Dore DD, Norman H, Loughlin J, et al. Extended case–control study results on thromboembolic outcomes among transdermal contraceptive users. Contraception. 2010;81:408–413.
- Younus I, Reddy DS. Seizure facilitating activity of the oral contraceptive ethinyl estradiol. Epilepsy Res. 2016;121:29–32.
- Buterbaugh GG. Estradiol replacement facilitates the acquisition of seizures kindled from the anterior neocortex in female rats. Epilepsy Res. 1989;4:207–215.
- Edwards HE, Burnham WM, MacLusky NJ. Testosterone and its metabolites affect afterdischarge thresholds and the development of amygdala kindled seizures. Brain Res. 1999;838:151–157.
- Reddy DS. Testosterone modulation of seizure susceptibility is mediated by neurosteroids 17β-estradiol and 3α-androstanediol. Neurosci. 2004;129:195–207.
- Murphy DD, Cole NB, Greenberger V. Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons. J Neurosci. 1998;18:2550–2559.
- Woolley CS, Weiland NG, McEwen BS. Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J Neurosci. 1997;17:1848–1859.
- Ruddick CN, Woolley CS. Estrogen regulates functional inhibition of hippocampal CA1 pyramidal cells in the adult female rat. J Neurosci. 2001;21:6532–6543.
- Zadran S, Qin Q, Bi X, et al. 17β-estradiol increases neuronal excitability through MAP kinase-induced calpain activation. Proc Natl Acad Sci USA. 2009;106:21936–21941.
- Roepke TA, Ronnekleiv OK, Kelly MJ. Physiological consequences of membrane-initiated estrogen signaling in the brain. Front Biosci (Landmark Ed). 2001;16:1560–1573.
- Herzog AG, Fowler KM, Smithson SD, et al. Progesterone trial study group. Progesterone vs placebo therapy for women with epilepsy: a randomized clinical trial. Neurol. 2012;78:1959–1966.
- Herzog AG, Frye CA, Progesterone Trial Study Group. Allopregnanolone levels and seizure frequency in progesterone-treated women with epilepsy. Neurol. 2014;83:345–458.
- Reddy DS, Estes WA, Clinical potential of neurosteroids for CNS disorders. Trends Pharmacol Sci. 2016;37(7):543–561.
- Reddy DS. Birth control pills may increase risk of seizures. Texas A&M Today. States News Service, March 30,2016.